Equity Research firms currently have a positive stance on shares of MediciNova Inc. (NASDAQ:MNOV). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $11.00 on a short term basis.
At the time of writing, the stock was trading at $7.15. This represents a change from the opening price of 1.42%. In terms of performance, year to date, the stock is 98.59%. The monthly stock performance comes in at 10.33%. For the quarter, shares are performing at -2.49%. Weekly performance analysis shows the equity at -5.11%.
In taking a look at technical levels, shares are trading 6.88% away from the 50 day simple moving average and 14.44% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -29.63% away from it’s 52- week high and 172.90% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, MediciNova Inc.’s RSI stands at 55.21. In looking at volatility levels, the shares saw weekly volatility of 3.07% and 3.79% over the past month.